Skip to content

Merit Medical Systems MMSI Non US Excluding Ireland — PP&E (Net)

Similar metrics at other companies

Wolfspeed logo
WOLFNon-US — PP&E (Net)
$142.9M-11.8%
Ashland logo
ASHNon Us — PP&E (Net)
$353M+3.2%
Cohu logo
COHUUS — PP&E (Net)
$13.9M+2.2%
Veeco Instruments logo
VECOUS — PP&E (Net)
$108.04M-4.4%
Badger Meter logo
BMIUS — PP&E (Net)
$46.32M+6.3%
Worthington Enterprises logo
WORUS — PP&E (Net)
$223.12M+7.4%

Other financials

Income statement

See full
Revenue$381.9M+7.5%
Gross profit$184.8M+7.4%
Operating income$44.2M+7.6%
Net income$41.0M+36.0%
EPS (diluted)$0.68+38.8%

Balance sheet

See full
Cash & equivalents$488.1M+23.4%
Total debt$821.6M+0.5%
Total equity$1.6B+13.9%
Total assets$2.7B+10.2%

Cash flow

See full
Operating cash flow$40.7M+0.3%
CapEx$16.0M-24.0%
Free cash flow$24.7M+26.5%

Valuation

See full
Market cap$4.01B-34.1%

Profitability

See full
Gross margin48.7%+0.9pp
Operating margin12.2%+0.6pp
Net margin9%+0.2pp
FCF margin14.3%+1.3pp

Returns & leverage

See full
Return on equity9.1%0.0pp
Debt / equity0.5×-0.1×
Current ratio5.1×+0.2×

Where this comes from

Reported directly by Merit Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Merit Medical Systems’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merit Medical Systems's non us excluding ireland — pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merit Medical Systems's non US excluding ireland — PP&E (net)?
Merit Medical Systems (MMSI) reported non US excluding ireland — PP&E (net) of $78.32M in Q4 2025.
How has Merit Medical Systems's non US excluding ireland — PP&E (net) changed year-over-year?
Merit Medical Systems's non US excluding ireland — PP&E (net) increased by 13.3% year-over-year, from $69.11M to $78.32M.
What does non US excluding ireland — PP&E (net) mean?
This metric represents the net book value of tangible long-term assets, such as manufacturing facilities, machinery, and equipment, located in international markets excluding Ireland. It serves as a proxy for the company's physical production footprint and capital investment intensity within these specific geographic regions. Monitoring this value helps investors assess the scale of regional operations and the potential for localized manufacturing efficiency.